Published in Blood Weekly, February 26th, 2009
"Technological innovations in microarrays, microfluidics, and nanotechnology make it feasible to study the evolution of sepsis in small animal models in considerable detail. The recognized limitations of standard...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.